Supported By: Boehringer Ingelheim Pharmaceuticals, Inc.
Exhibit Hall, Learning Theater 1
Boston Convention and Exhibition Center

Program Description

Please join pulmonologist Mridu Gulati, MD, MPH, as she provides insight into the journey of the interstitial lung disease (ILD) patient. Dr. Gulati will highlight key signs and symptoms, discuss the importance of high-resolution CT (HRCT) scans in diagnosis, and the need for early diagnosis and comprehensive supportive care for patients with ILD. Dr. Gulati will be joined by patient mentor, Kay B., who will share her experience of the diagnostic journey and challenges of living with ILD. This presentation is made on behalf of Boehringer Ingelheim Pharmaceuticals, Inc.

This is a non-CME event and does not qualify for CME, CE, or MOC credit. This event is not part of the official CHEST Annual Meeting 2024 conference sessions. This event is not endorsed by CHEST and does not reflect  the views or opinions of CHEST.

This presentation is open to all CHEST 2024 attendees. Onsite registration will occur for conference registrants only at the presentation entrance on a first-come, first-served basis. Presentation content has been reviewed for consistency with FDA guidelines and is not approved for continuing education credit. Speakers receive fair market value compensation for this presentation. Aspects of this program may be reportable under the Physicians Payment Sunshine Act. Pursuant to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals, attendance at this promotional program is limited to healthcare professionals, attendance by healthcare professionals’ spouses or guests is not permitted.

Speaker

Presenter: Mridu Gulati, MD, MPH
Yale School of Medicine
Yale Interstitial Lung Disease Program
Associate Director
New Haven, CT